|
Delayed
NSE India S.E.
06:53:50 17/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 5,198.50 INR | +1.22% |
|
-4.55% | -5.57% |
| 11-12 | Alkem Laboratories Limited, Q2 2027 Earnings Call, Nov 12, 2026 | |
| 11-12 | Alkem Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALKEM LABORATORIES LIMITED | Other Pharmaceuticals | +1.22% | -4.55% | -5.57% | -9.14% | +49.56% | 6.54B |
- Stock Market
- Stocks
- ALKEM Stock
- Charts Alkem Laboratories Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















